SP
Sermonix Pharmaceuticals, Inc. disclosed a 25.1% stake in LONA
Sermonix Pharmaceuticals, Inc. reported owning 25.1% of LeonaBio, Inc. (LONA) (3,149,470 shares) in a Schedule 13D filed Oct 28, 2026.
A 13D means the holder may push for changes at the company.